Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C21H18NO4 |
| Molecular Weight | 348.3719 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 1 |
SHOW SMILES / InChI
SMILES
COC1=CC=C2C(C=[N+](C)C3=C2C=CC4=C3C=C5OCOC5=C4)=C1OC
InChI
InChIKey=LLEJIEBFSOEYIV-UHFFFAOYSA-N
InChI=1S/C21H18NO4/c1-22-10-16-13(6-7-17(23-2)21(16)24-3)14-5-4-12-8-18-19(26-11-25-18)9-15(12)20(14)22/h4-10H,11H2,1-3H3/q+1
| Molecular Formula | C21H18NO4 |
| Molecular Weight | 348.3719 |
| Charge | 1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Chelerythrine is a kind of benzo[c] phenanthridine alkaloids, which is widely found in plant of Fumariaceae, Papaveraceae, Ranunculaceae and Rutaceae families. Chelerythrine is a potent and specific inhibitor of protein kinase C. In addition chelerythrine inhibits pro-survival protein Bcl(XL) thereby inducing apoptosis. It exerts antitumor properties.
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9666086 | https://www.ncbi.nlm.nih.gov/pubmed/7619317
Curator's Comment: Centrally administered chelerythrine is CNS active in animals. No human data available.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL2093867 Sources: https://www.ncbi.nlm.nih.gov/pubmed/2244923 |
0.7 µM [Ki] | ||
Target ID: CHEMBL4625 |
|||
Target ID: CHEMBL235 Sources: https://www.ncbi.nlm.nih.gov/pubmed/26183621 |
566.0 nM [IC50] | ||
Target ID: CHEMBL2311221 |
|||
Target ID: CHEMBL2093867 Sources: https://adisinsight.springer.com/drugs/800013523 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Role of protein kinase C in the signal pathways that link Na+/K+-ATPase to ERK1/2. | 2001-11-09 |
|
| Differentiation of bipolar CG-4 line oligodendrocytes is associated with regulation of CREB, MAP kinase and PKC signalling pathways. | 2001-11 |
|
| Activation of PKC decreases myocardial O2 consumption and increases contractile efficiency in rats. | 2001-11 |
|
| Mechanisms of the apoptotic and necrotic actions of trimethyltin in cerebellar granule cells. | 2001-11 |
|
| Novel role of macrophage migration inhibitory factor in angiotensin II regulation of neuromodulation in rat brain. | 2001-11 |
|
| Differential MAP kinase activation and Na(+)/H(+) exchanger phosphorylation by H(2)O(2) in rat cardiac myocytes. | 2001-11 |
|
| Adenosine A(2A) and A(2B) receptor activation of erythropoietin production. | 2001-11 |
|
| Characterization of the signal transduction pathways mediating morphine withdrawal-stimulated c-fos expression in hypothalamic nuclei. | 2001-10-26 |
|
| Stimulatory effect of phenylephrine on the secretion of beta-endorphin from rat adrenal medulla in vitro. | 2001-10-08 |
|
| Chelerythrine rapidly induces apoptosis through generation of reactive oxygen species in cardiac myocytes. | 2001-10 |
|
| Death by protein kinase C inhibitor: a stressful event. | 2001-10 |
|
| Endothelium-derived endothelin-1 reduces cerebral artery sensitivity to nitric oxide by a protein kinase C-independent pathway. | 2001-10 |
|
| Protein kinase C and changes in manganese superoxide dismutase gene expression in cultured glial cells. | 2001-10 |
|
| Role of Na(+)/H(+) exchanger during O(2) deprivation in mouse CA1 neurons. | 2001-10 |
|
| Regulation and distribution of MAdCAM-1 in endothelial cells in vitro. | 2001-10 |
|
| Protein kinase C regulation of cell spreading in the molluscan Biomphalaria glabrata embryonic (Bge) cell line. | 2001-09-26 |
|
| A diacylglycerol-activated Ca2+ channel in PC12 cells (an adrenal chromaffin cell line) correlates with expression of the TRP-6 (transient receptor potential) protein. | 2001-09-15 |
|
| Protein kinase C regulates dopamine D4 receptor-mediated phospholipid methylation. | 2001-09-14 |
|
| A new diprenyl coumarin and alkaloids from the bark of Zanthoxylum dimorphophyllum (Rutaceae). | 2001-09-04 |
|
| The lysophospholipids sphingosine-1-phosphate and lysophosphatidic acid enhance survival during hypoxia in neonatal rat cardiac myocytes. | 2001-09 |
|
| Src and multiple MAP kinase activation in cardiac hypertrophy and congestive heart failure under chronic pressure-overload: comparison with acute mechanical stretch. | 2001-09 |
|
| Role of calcineurin in insulin-like growth factor-1-induced hypertrophy of cultured adult rat ventricular myocytes. | 2001-09 |
|
| Mechanism of action of angiotensin II in human isolated subcutaneous resistance arteries. | 2001-09 |
|
| Regulation of ATP-sensitive K(+) channels by protein kinase C in murine colonic myocytes. | 2001-09 |
|
| Induction of osteoblast differentiation indexes by PTHrP in MG-63 cells involves multiple signaling pathways. | 2001-09 |
|
| Evidence for two mechanisms of amino acid osmolyte release from hippocampal slices. | 2001-08 |
|
| The effects of isoflurane on native and chimeric muscarinic acetylcholine receptors: the role of protein kinase C. | 2001-08 |
|
| Diminished alpha1-adrenergic-mediated contraction and translocation of PKC in senescent rat heart. | 2001-08 |
|
| Inhibition of acetylcholine-activated K(+) current by chelerythrine and bisindolylmaleimide I in atrial myocytes from mice. | 2001-07-27 |
|
| Chelerythrine and genistein inhibit the endothelin-1-induced increase in myofilament Ca(2+) sensitivity in rabbit ventricular myocytes. | 2001-07-20 |
|
| Opioid receptor stimulation acts as mediator of protection in ischaemic preconditioning. | 2001-07-12 |
|
| Evidence for a role of protein kinase C in FGF signal transduction in the developing chick limb bud. | 2001-07 |
|
| Backtable heat-enhanced preconditioning: a simple and effective means of improving function of heart transplants. | 2001-07 |
|
| Role of protein kinase C in the reduction of infarct size by N-methyl-1-deoxynojirimycin, an alpha-1,6-glucosidase inhibitor. | 2001-07 |
|
| Activation of extracellular signal-regulated kinase in trabecular meshwork cells. | 2001-07 |
|
| Histamine increases interstitial adenosine concentration via activation of ecto-5'-nucleotidase in rat hearts in vivo. | 2001-07 |
|
| Differential effects of protein kinase C on human vascular smooth muscle cell proliferation and migration. | 2001-07 |
|
| Heat shock prevents simulated ischemia-induced apoptosis in renal tubular cells via a PKC-dependent mechanism. | 2001-07 |
|
| ANG II-mediated inhibition of neuronal delayed rectifier K+ current: role of protein kinase C-alpha. | 2001-07 |
|
| Post-ischemic PKC inhibition impairs myocardial calcium handling and increases contractile protein calcium sensitivity. | 2001-07 |
|
| Involvement of protein kinase C and tyrosine kinase in lipopolysaccharide-induced anorexia. | 2001-06-23 |
|
| Protein kinase A- and C-dependent modulation of murine inducible nitric oxide synthase. | 2001-06 |
|
| Stathmin levels in growth plate chondrocytes are modulated by vitamin D3 metabolites and transforming growth factor-beta1 and are associated with proliferation. | 2001-06 |
|
| Role of protein kinase C and phosphatases in the pulmonary vasculature of neonatal piglets. | 2001-06 |
|
| Vasopressin-induced protein kinase C-dependent superoxide generation contributes to atp-sensitive potassium channel but not calcium-sensitive potassium channel function impairment after brain injury. | 2001-06 |
|
| Capsaicin potentiates 1,25-dihydoxyvitamin D3- and all-trans retinoic acid-induced differentiation of human promyelocytic leukemia HL-60 cells. | 2001-05-25 |
|
| Stimulatory effect of isoferulic acid on alpha1A-adrenoceptor to increase glucose uptake into cultured myoblast C2C12 cell of mice. | 2001-05-14 |
|
| Protein phosphorylation in mitochondria from human placenta. | 2001-05 |
|
| High calcium and dobutamine positive inotropy in the perfused mouse heart: myofilament calcium responsiveness, energetic economy, and effects of protein kinase C inhibition. | 2001 |
|
| Interaction of benzo[c]phenanthridine and protoberberine alkaloids with animal and yeast cells. | 2001 |
Sample Use Guides
Mice injected i.p. with chelerythrine 1-10 mg/kg
Route of Administration:
Intraperitoneal
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/24518719
10 ug/mL of chelerythrine is capable of inducing apoptosis in Dalton's lymphoma (DL) cells.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:59:42 GMT 2025
by
admin
on
Mon Mar 31 19:59:42 GMT 2025
|
| Record UNII |
E3B045W6X0
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
E3B045W6X0
Created by
admin on Mon Mar 31 19:59:42 GMT 2025 , Edited by admin on Mon Mar 31 19:59:42 GMT 2025
|
PRIMARY | |||
|
34316-15-9
Created by
admin on Mon Mar 31 19:59:42 GMT 2025 , Edited by admin on Mon Mar 31 19:59:42 GMT 2025
|
PRIMARY | |||
|
2703
Created by
admin on Mon Mar 31 19:59:42 GMT 2025 , Edited by admin on Mon Mar 31 19:59:42 GMT 2025
|
PRIMARY | |||
|
DTXSID20861211
Created by
admin on Mon Mar 31 19:59:42 GMT 2025 , Edited by admin on Mon Mar 31 19:59:42 GMT 2025
|
PRIMARY | |||
|
CHELERYTHRINE
Created by
admin on Mon Mar 31 19:59:42 GMT 2025 , Edited by admin on Mon Mar 31 19:59:42 GMT 2025
|
PRIMARY | |||
|
78373
Created by
admin on Mon Mar 31 19:59:42 GMT 2025 , Edited by admin on Mon Mar 31 19:59:42 GMT 2025
|
PRIMARY | |||
|
m3320
Created by
admin on Mon Mar 31 19:59:42 GMT 2025 , Edited by admin on Mon Mar 31 19:59:42 GMT 2025
|
PRIMARY | Merck Index | ||
|
C016299
Created by
admin on Mon Mar 31 19:59:42 GMT 2025 , Edited by admin on Mon Mar 31 19:59:42 GMT 2025
|
PRIMARY | |||
|
251-930-0
Created by
admin on Mon Mar 31 19:59:42 GMT 2025 , Edited by admin on Mon Mar 31 19:59:42 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
|
||
|
|
SALT/SOLVATE -> PARENT |
|
||
|
TARGET -> INHIBITOR | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|